Browsing Tag
Parker-Hannifin
1 post
QIAGEN changed CEO while its board is reviewing strategic options. What does Jonathan Pratt inherit?
Jonathan Pratt has taken over as QIAGEN CEO after leading Filtration Group through its sale to Parker-Hannifin, inheriting a life-sciences company with a 29.4% adjusted operating margin, $301 million of first-half operating cash flow and an unresolved board-led strategic review.
September 1, 2026